Cytora Therapeutics Ltd.
PrivateCompany Overview
Cytora Therapeutics Ltd. is a biotechnology company that develops allogeneic, off-the-shelf stem cell therapies derived from human oral mucosa stem cells for the treatment of chronic wounds and neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytora Therapeutics Ltd. Comparables
Compare Cytora Therapeutics Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stempeutics Research | 78% | |
| RHEACELL GmbH & Co. KG | 76% | |
| BL Pharmtech Corp. | 72% | |
Cytora Therapeutics Ltd. Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Cytora Therapeutics Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed, Grant |
| Tadmor Group | Seed |
Cytora Therapeutics Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cytora Therapeutics Ltd.'s valuation, stock price, and market status.